XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer

BACKGROUND: For a long time, breast cancer has been a leading cancer diagnosed in women worldwide, and approximately 90% of cancer-related deaths are caused by metastasis. For this reason, finding new biomarkers related to metastasis is an urgent task to predict the metastatic status of breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingqing, Yang, Hui, Wang, Peipei, Liu, Xiaocen, Lv, Kun, Ye, Mingquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014628/
https://www.ncbi.nlm.nih.gov/pubmed/35436939
http://dx.doi.org/10.1186/s12967-022-03369-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014628/
https://www.ncbi.nlm.nih.gov/pubmed/35436939
http://dx.doi.org/10.1186/s12967-022-03369-9

Ejemplares similares